Anal fistula medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 5: | Line 5: | ||
==Pharmocotherapy== | ==Pharmocotherapy== | ||
*Empiric therapy for anal fistula depends on | *Empiric therapy for anal fistula depends on following factors: | ||
* | **Location of anal fistula. | ||
**Signs and symptoms of abscess. | |||
*Main stay of therapy is surgical management. | |||
*Antibiotics are given in the following condition: | |||
**Immunosuppression | |||
**Diabetes | |||
**Extensive cellulitis | |||
**Prosthetic devices | |||
**High-risk cardiac patient | |||
==References== | ==References== | ||
Revision as of 17:00, 30 January 2018
|
Anal fistula Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Anal fistula medical therapy On the Web |
|
American Roentgen Ray Society Images of Anal fistula medical therapy |
|
Risk calculators and risk factors for Anal fistula medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
Pharmocotherapy
- Empiric therapy for anal fistula depends on following factors:
- Location of anal fistula.
- Signs and symptoms of abscess.
- Main stay of therapy is surgical management.
- Antibiotics are given in the following condition:
- Immunosuppression
- Diabetes
- Extensive cellulitis
- Prosthetic devices
- High-risk cardiac patient